COVID-19 is an infection induced by the SARS-CoV-2 coronavirus, and severe forms can
lead to acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) …

Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …

Abstract Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory
response, disordered hemostasis and high thrombotic risk. A high incidence of …

Background Intermittent locking of central venous catheters (CVCs) is undertaken to help
maintain their patency and performance. There are systematic variations in care: some …

Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-
immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct …

Knowledge on heparin-induced thrombocytopenia keeps increasing. Recent progress on
diagnosis and management as well as several discoveries concerning its pathogenesis …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic immune drug reaction caused
by platelet-activating antibodies that in most instances recognize platelet factor 4 …

Background Hospitalized patients with COVID‐19 suffered initially from high rates of venous
thromboembolism (VTE), with possible associations between therapeutic anticoagulation …

Severe cases of cerebral venous thrombosis (CVT) with thrombocytopenia and anti-platelet
factor 4 (PF4) antibodies occurring after adenoviral vector anti-SARS-CoV-2 vaccines have …

Background This is a review article on heparin-induced thrombocytopenia, an adverse effect
of heparin therapy, and vaccine-induced immune thrombotic thrombocytopenia, occurring in …